Search

Your search keyword '"Żotkiewicz, M."' showing total 3 results
Start Over Author "Żotkiewicz, M." Topic placebos
3 results on '"Żotkiewicz, M."'

1. Corrigendum to "78P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC)": [Annals of Oncology 33 (2022) S1462-S1463]

Author

Oh, D., He, A.R., Qin, S., Chen, L., Okusaka, T., Vogel, A., Kim, J.W., Suksombooncharoen, T., Lee, M.A., Kitano, M., Burris, H.A., Bouattour, M., Tanasa, S., Zaucha, R.E., Avallone, A., Cundom, J.E., Rokutanda, N., Żotkiewicz, M., Cohen, G., and Valle, J.W.

Subjects
*OVERALL survival, *CISPLATIN, *GEMCITABINE, *PLACEBOS, BILIARY tract cancer
Published
2023
Full Text
View/download PDF

2. 78P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC).

Author

Oh, D-Y., He, A.R., Qin, S., Chen, L-T., Okusaka, T., Vogel, A., Kim, J.W., Lee, T., Lee, M.A., Kitano, M., Burris, H.A., Bouattour, M., Tanasanvimon, S., Zaucha, R.E., Avallone, A., Cundom, J.E., Rokutanda, N., Żotkiewicz, M., Cohen, G., and Valle, J.W.

Subjects
*OVERALL survival, *CISPLATIN, *GEMCITABINE, *PLACEBOS, BILIARY tract cancer
Published
2022
Full Text
View/download PDF

3. 68O Impact of mutation status on efficacy outcomes in TOPAZ-1: A phase III study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+GC) in advanced biliary tract cancer (BTC).

Author

Valle, J.W., Qin, S., Antonuzzo, L., Tougeron, D., Lee, C-K., Tan, B.J., Ikeda, M., Guthrie, V., McCoon, P., Lee, Y.S., Rokutanda, N., Żotkiewicz, M., Cohen, G., and Oh, D-Y.

Subjects
*TREATMENT effectiveness, *CISPLATIN, *GEMCITABINE, *PLACEBOS, BILIARY tract cancer
Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results